文献速递神经肿瘤小儿神经外科与脑积水

儿童期起病脑肿瘤患者的长期内分泌影响及体重指数变化趋势

Long-term endocrine effects and trends in body mass index changes in patients with childhood-onset brain tumors.
PubMed 文献 · J Neurooncol · 2018-01-19

该研究回顾性纳入1995年1月至2016年12月诊断的151例儿童期起病脑肿瘤患者,分析肿瘤位置、组织学、内分泌异常、影像下丘脑受累、治疗方式及体重指数趋势。鞍区/鞍上肿瘤患者联合垂体激素缺乏症患病率高于幕上/幕下肿瘤患者(81.7% vs 36.1%,P<0.001)。98例鞍区/鞍上肿瘤非肥胖患者中36.7%发生肥胖。

要点

  • 鞍区/鞍上肿瘤患者联合垂体激素缺乏症患病率81.7%,高于幕上/幕下肿瘤患者的36.1%(P<0.001)。
  • 98例鞍区/鞍上肿瘤非肥胖患者中36.7%发生肥胖。
  • 幕上/幕下肿瘤患者最终随访时身高标准差评分更低(P<0.001)。

核心结论

  • 鞍区/鞍上肿瘤患者联合垂体激素缺乏症和肥胖患病率高于其他位置肿瘤患者,幕上/幕下肿瘤患者生长障碍更严重。

研究设计与样本

  • 回顾性研究纳入1995年1月至2016年12月诊断的151例儿童期起病脑肿瘤患者,回顾肿瘤位置、组织学、内分泌异常、影像下丘脑受累、治疗方式及体重指数趋势。

主要发现

  • 鞍区/鞍上肿瘤患者诊断时平均年龄9.9±4.5岁,幕上/幕下肿瘤患者6.5±4.2岁。
  • 诊断时为青春期前患者中,鞍区/鞍上肿瘤患者诊断时身高标准差评分较低(P=0.031)。
  • 诊断时为青春期前患者中,幕上/幕下肿瘤患者最终随访时身高标准差评分较低(P<0.001)。
  • 鞍区/鞍上肿瘤患者联合垂体激素缺乏症患病率81.7%,高于幕上/幕下肿瘤患者的36.1%(P<0.001)。
  • 98例鞍区/鞍上肿瘤非肥胖患者中36.7%发生肥胖。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As survival rates have improved owing to advances in management strategies for pediatric brain tumors, long-term complications such as endocrine dysfunction, have emerged as a major issue. This study investigated the long-term endocrine effects of childhood-onset brain tumors in a large number of patients. This study included 151 patients with brain tumors diagnosed between January 1995 and December 2016. The following data were retrospectively reviewed: tumor location, tumor histology, endocrine abnormalities, hypothalamic involvement on brain imaging, treatment modalities, and trends in body mass index. The mean age at diagnosis of patients with sellar/suprasellar (SE/SUP-SE) tumors and supra/infratentorial (ST/IT) tumors was 9.9 ± 4.5 and 6.5 ± 4.2 years, respectively. In patient with prepubertal age at diagnosis, height standard deviation score was lower in patients with SE/SUP-SE tumors at diagnosis (P = 0.031), which was lower in patients with ST/IT tumors at the final visit (P < 0.001). The prevalence of combined pituitary hormone deficiencies was higher among patients with SE/SUP-SE tumors than in those with ST/IT tumors (81.7 vs. 36.1%, P < 0.001). Among 98 non-obese patients with SE/SUP-SE tumors, 36.7% developed obesity. The prevalence of combined pituitary hormone deficiencies and obesity was higher in patients with SE/SUP-SE tumors than in those with tumors in other locations; growth impairment was more severe in patients with ST/IT tumors.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Seo GH, Choi JH, Kim YM, et al. Long-term endocrine effects and trends in body mass index changes in patients with childhood-onset brain tumors. J Neurooncol. 2018. PMID: 29352447. doi:10.1007/s11060-018-2765-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。